The Toxic Exposures Research Program is a new CDMRP program that will allow the research community to improve the scientific understanding of pathobiology from toxic exposures, more efficiently assess comorbidities, and speed the development of treatments, cures, and preventions. This message is being sent to individuals subscribed to multiple applicable programs to ensure widest dissemination.
FY22 Funding Opportunities released:
Toxic Exposures Research Program (TERP)
- Investigator-Initiated Research Award
- Translational Research Award (with Partnering Principal Investigator Option)
- Clinical Trial Award (with Partnering Principal Investigator Option)
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Funding Opportunities/Program Announcements and General Application Instructions which can be found on the Grants.gov website (https://Grants.gov). A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using Assistance Listing (formerly CFDA) Number 12.420.
New for FY22: The applicant organization must be registered as an entity in SAM (https://www.sam.gov/SAM/ ) and receive confirmation of an “Active” status before submitting an application through Grants.gov. As published in the Federal Register 10 July 2019 (https://www.federalregister.gov/documents/2019/07/10/2019-14665/unique-entity-id-standard-for-awards-management), the Unique Entity Identifier for awards management generated through SAM will replace the Data Universal Numbering System (DUNS) number as of April 2022. CDMRP has transitioned to use of the Unique Entity Identifier (SAM) and will utilize the latest SF 424 which includes the UEI. The DUNS will no longer be accepted.
For email notification when CDMRP funding opportunities are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.health.mil).
For more information on types of funding opportunities offered and application strategies review the CDMRP Webinar Series: https://cdmrp.health.mil/pubs/Webinars/webinar_series.
Please do not respond directly to this message. To be added or removed from this email list please use the "Subscribe/unsubscribe" to program specific news and updates at https://ebrap.org.
CDMRP also provides news and updates through Twitter and YouTube.
Follow CDMRP on Twitter: https://twitter.com/CDMRP
Subscribe to CDMRP on YouTube: http://www.youtube.com/CDMRP
Follow CDMRP on Facebook: https://www.facebook.com/TheCDMRP